While numerous approaches of targeting glutamine metabolism in cancer have been proposed and tested over the last several decades [32,33,34], inhibition of glutamine catabolism by glutaminase has emerged as a major focus of both academic and pharmaceutical cancer metabolism research. Here, GLS is linked to cancer.